ICON survey report
Exploring the application of methods and technologies advancing CNS therapeutic development
Advances in the technologies and methodologies used in CNS clinical trials have played a pivotal role in the development of the first disease-modifying treatments for Alzheimer’s.
To better understand trends in adoption and application of these innovative technologies and methodologies, ICON surveyed 129 CNS developers focused on neurodegenerative CNS conditions.
Explore the results to learn:
- High-level trends in CNS therapeutic pipelines and investment areas
- Key challenges, opportunities and areas of innovation in CNS therapeutic development
- Adoption and application of technologies like AI, biomarkers and digital health technologies
- Adoption and application of clinical trial methodologies like master protocols, registries and tokenisation
- How approaches to trial design and technology adoption differed by organisation size, region, focus indications and stages of clinical development
ICON survey report
Exploring the application of methods and technologies advancing CNS therapeutic development.